vs
CAL-MAINE FOODS INC（CALM）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是CAL-MAINE FOODS INC的1.0倍（$772.1M vs $769.5M），CAL-MAINE FOODS INC净利率更高（13.4% vs 12.7%，领先0.6%），Revvity同比增速更快（5.9% vs -19.4%），Revvity自由现金流更多（$161.8M vs $47.9M），过去两年CAL-MAINE FOODS INC的营收复合增速更高（29.4% vs 9.0%）
卡尔梅恩食品公司是总部位于美国密西西比州里奇兰的鲜蛋生产商，截至2024年是美国规模最大的蛋品企业。公司旗下拥有Egg-Land's Best、Land O'Lakes等多个知名蛋品品牌，1957年由弗雷德·R·亚当斯二世创立，亚当斯家族持有企业控股权，目前在纳斯达克挂牌上市。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
CALM vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.0倍
$769.5M
营收增速更快
RVTY
高出25.2%
-19.4%
净利率更高
CALM
高出0.6%
12.7%
自由现金流更多
RVTY
多$113.9M
$47.9M
两年增速更快
CALM
近两年复合增速
9.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $769.5M | $772.1M |
| 净利润 | $102.8M | $98.4M |
| 毛利率 | 27.0% | — |
| 营业利润率 | 16.1% | 14.5% |
| 净利率 | 13.4% | 12.7% |
| 营收同比 | -19.4% | 5.9% |
| 净利润同比 | -53.1% | 3.9% |
| 每股收益（稀释后） | $2.13 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CALMRVTY
| Q4 25 | $769.5M | $772.1M | ||
| Q3 25 | $922.6M | $698.9M | ||
| Q2 25 | — | $720.3M | ||
| Q1 25 | $1.4B | $664.8M | ||
| Q4 24 | $954.7M | $729.4M | ||
| Q3 24 | $785.9M | $684.0M | ||
| Q2 24 | — | $691.7M | ||
| Q1 24 | $703.1M | $649.9M |
净利润CALMRVTY
| Q4 25 | $102.8M | $98.4M | ||
| Q3 25 | $199.3M | $46.7M | ||
| Q2 25 | — | $53.9M | ||
| Q1 25 | $508.5M | $42.2M | ||
| Q4 24 | $219.1M | $94.6M | ||
| Q3 24 | $150.0M | $94.4M | ||
| Q2 24 | — | $55.4M | ||
| Q1 24 | $146.7M | $26.0M |
毛利率CALMRVTY
| Q4 25 | 27.0% | — | ||
| Q3 25 | 33.7% | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | 50.5% | 56.5% | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 31.5% | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | 31.1% | 54.6% |
营业利润率CALMRVTY
| Q4 25 | 16.1% | 14.5% | ||
| Q3 25 | 27.0% | 11.7% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | 44.8% | 10.9% | ||
| Q4 24 | 29.1% | 16.3% | ||
| Q3 24 | 23.8% | 14.3% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | 23.2% | 6.8% |
净利率CALMRVTY
| Q4 25 | 13.4% | 12.7% | ||
| Q3 25 | 21.6% | 6.7% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | 35.9% | 6.4% | ||
| Q4 24 | 22.9% | 13.0% | ||
| Q3 24 | 19.1% | 13.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | 20.9% | 4.0% |
每股收益（稀释后）CALMRVTY
| Q4 25 | $2.13 | $0.86 | ||
| Q3 25 | $4.12 | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | $10.38 | $0.35 | ||
| Q4 24 | $4.47 | $0.77 | ||
| Q3 24 | $3.06 | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | $3.00 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $369.4M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $7.3B |
| 总资产 | $3.1B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CALMRVTY
| Q4 25 | $369.4M | $919.9M | ||
| Q3 25 | $251.9M | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | $497.2M | $1.1B | ||
| Q4 24 | $140.3M | $1.2B | ||
| Q3 24 | $181.7M | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $367.1M | $1.7B |
股东权益CALMRVTY
| Q4 25 | $2.7B | $7.3B | ||
| Q3 25 | $2.7B | $7.4B | ||
| Q2 25 | — | $7.6B | ||
| Q1 25 | $2.4B | $7.6B | ||
| Q4 24 | $2.0B | $7.7B | ||
| Q3 24 | $1.9B | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | $1.7B | $7.8B |
总资产CALMRVTY
| Q4 25 | $3.1B | $12.2B | ||
| Q3 25 | $3.2B | $12.1B | ||
| Q2 25 | — | $12.4B | ||
| Q1 25 | $3.1B | $12.4B | ||
| Q4 24 | $2.5B | $12.4B | ||
| Q3 24 | $2.4B | $12.8B | ||
| Q2 24 | — | $13.4B | ||
| Q1 24 | $2.1B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $94.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $47.9M | $161.8M |
| 自由现金流率自由现金流/营收 | 6.2% | 21.0% |
| 资本支出强度资本支出/营收 | 6.1% | 2.6% |
| 现金转化率经营现金流/净利润 | 0.92× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $895.9M | $509.4M |
8季度趋势，按日历期对齐
经营现金流CALMRVTY
| Q4 25 | $94.8M | $182.0M | ||
| Q3 25 | $278.6M | $138.5M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | $571.6M | $128.2M | ||
| Q4 24 | $122.7M | $174.2M | ||
| Q3 24 | $117.5M | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | $164.0M | $147.6M |
自由现金流CALMRVTY
| Q4 25 | $47.9M | $161.8M | ||
| Q3 25 | $233.3M | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | $521.8M | $112.2M | ||
| Q4 24 | $92.9M | $149.8M | ||
| Q3 24 | $81.7M | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | $133.8M | $129.7M |
自由现金流率CALMRVTY
| Q4 25 | 6.2% | 21.0% | ||
| Q3 25 | 25.3% | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | 36.8% | 16.9% | ||
| Q4 24 | 9.7% | 20.5% | ||
| Q3 24 | 10.4% | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | 19.0% | 20.0% |
资本支出强度CALMRVTY
| Q4 25 | 6.1% | 2.6% | ||
| Q3 25 | 4.9% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | 3.5% | 2.4% | ||
| Q4 24 | 3.1% | 3.4% | ||
| Q3 24 | 4.6% | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | 4.3% | 2.7% |
现金转化率CALMRVTY
| Q4 25 | 0.92× | 1.85× | ||
| Q3 25 | 1.40× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | 1.12× | 3.03× | ||
| Q4 24 | 0.56× | 1.84× | ||
| Q3 24 | 0.78× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 1.12× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CALM
| Retail | $625.4M | 81% |
| Prepared Foods | $71.7M | 9% |
| Egg Products | $34.5M | 4% |
| Service Other | $19.2M | 2% |
| Other | $13.8M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
